Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
$6.57
+13.3%
$6.59
$1.88
▼
$9.28
$86.97M0.16240,467 shs163,212 shs
CorMedix Inc stock logo
CRMD
CorMedix
$4.50
-3.6%
$6.96
$4.49
▼
$13.02
$371.44M1.482.17 million shs1.60 million shs
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$3.69
+1.1%
$4.00
$2.44
▼
$13.15
$366.93M0.982.36 million shs1.70 million shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$2.25
-4.3%
$3.28
$2.23
▼
$15.70
$347.30M2.044.96 million shs5.07 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
+11.32%+9.43%-19.22%-24.18%+205.26%
CorMedix Inc stock logo
CRMD
CorMedix
-3.11%-13.04%-35.67%-45.19%-53.21%
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
+1.67%+2.24%-9.20%-42.79%-50.14%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+0.43%-11.32%-22.70%-51.35%-77.18%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
$6.57
+13.3%
$6.59
$1.88
▼
$9.28
$86.97M0.16240,467 shs163,212 shs
CorMedix Inc stock logo
CRMD
CorMedix
$4.50
-3.6%
$6.96
$4.49
▼
$13.02
$371.44M1.482.17 million shs1.60 million shs
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$3.69
+1.1%
$4.00
$2.44
▼
$13.15
$366.93M0.982.36 million shs1.70 million shs
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$2.25
-4.3%
$3.28
$2.23
▼
$15.70
$347.30M2.044.96 million shs5.07 million shs
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
+11.32%+9.43%-19.22%-24.18%+205.26%
CorMedix Inc stock logo
CRMD
CorMedix
-3.11%-13.04%-35.67%-45.19%-53.21%
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
+1.67%+2.24%-9.20%-42.79%-50.14%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
+0.43%-11.32%-22.70%-51.35%-77.18%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
1.00
SellN/AN/A
CorMedix Inc stock logo
CRMD
CorMedix
2.80
Moderate Buy$15.22238.57% Upside
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
2.50
Moderate Buy$23.33528.08% Upside
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
2.38
Hold$5.90161.64% Upside

Current Analyst Ratings Breakdown

Latest CPIX, CRMD, SPRY, and TLRY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/13/2026
CorMedix Inc stock logo
CRMD
CorMedix
Reiterated RatingOutperform$15.00 ➝ $13.00
11/10/2026
CorMedix Inc stock logo
CRMD
CorMedix
DowngradeHold (C+) ➝ Hold (C)
11/10/2026
CorMedix Inc stock logo
CRMD
CorMedix
Set Price Target$19.00
11/10/2026
CorMedix Inc stock logo
CRMD
CorMedix
Reiterated RatingMarket Outperform
11/10/2026
CorMedix Inc stock logo
CRMD
CorMedix
Boost Price TargetOutperform$14.00 ➝ $15.00
11/10/2026
CorMedix Inc stock logo
CRMD
CorMedix
Boost Price TargetBuy$12.00 ➝ $14.00
11/9/2026
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
UpgradeSell (E+) ➝ Sell (D-)
11/6/2026
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
DowngradeStrong-Buy ➝ Outperform
11/2/2026
CorMedix Inc stock logo
CRMD
CorMedix
Lower Price TargetBuy$15.00 ➝ $12.00
10/23/2026
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
DowngradeSell (D-) ➝ Sell (E+)
10/19/2026
CorMedix Inc stock logo
CRMD
CorMedix
Reiterated RatingBuy$15.00
(Data available from 11/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
$44.52M2.17$0.45 per share14.21$4.81 per share1.34
CorMedix Inc stock logo
CRMD
CorMedix
$311.71M1.15$1.91 per share2.36$5.80 per share0.78
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
$84.28M4.43N/AN/A($0.12) per share-30.96
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
$210.48M1.58N/AN/A$13.68 per share0.16
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
-$2.84M$4.491.42N/AN/A274.38%-19.50%-8.12%N/A
CorMedix Inc stock logo
CRMD
CorMedix
$163.05M$0.696.5229.971.1115.49%26.70%13.61%N/A
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
-$171.30M-$2.02N/AN/AN/A-163.64%-453.93%-71.62%N/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$121.40M-$1.40N/AN/AN/A-16.91%-10.39%-7.38%1/11/2027 (Estimated)

Latest CPIX, CRMD, SPRY, and TLRY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
CorMedix Inc stock logo
CRMD
CorMedix
-$0.12-$0.19-$0.07-$0.19$51.76 million$54.52 million
11/5/2026Q3 2026
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
-$0.3050-$0.36-$0.0550-$0.36$41.99 million$37.71 million
10/8/2026Q1 2027
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
-$0.1814-$0.02+$0.1614-$0.32$266.26 million$257.15 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
N/AN/AN/AN/AN/A
CorMedix Inc stock logo
CRMD
CorMedix
N/AN/AN/AN/AN/A
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
N/AN/AN/AN/AN/A
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
N/A
3.05
0.96
CorMedix Inc stock logo
CRMD
CorMedix
0.31
2.43
2.36
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
13.72
3.25
3.07
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
0.17
1.88
1.11

Institutional Ownership

CompanyInstitutional Ownership
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
15.51%
CorMedix Inc stock logo
CRMD
CorMedix
34.18%
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
68.16%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
9.35%

Insider Ownership

CompanyInsider Ownership
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
42.07%
CorMedix Inc stock logo
CRMD
CorMedix
3.50%
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
33.80%
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
1.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cumberland Pharmaceuticals Inc. stock logo
CPIX
Cumberland Pharmaceuticals
9315.00 million8.68 millionOptionable
CorMedix Inc stock logo
CRMD
CorMedix
19179.54 million76.75 millionOptionable
ARS Pharmaceuticals, Inc. stock logo
SPRY
ARS Pharmaceuticals
206100.53 million66.55 millionOptionable
Tilray Brands, Inc. stock logo
TLRY
Tilray Brands
3,595147.79 million145.42 millionOptionable

Recent News About These Companies

Financial Analysis: Tilray Brands (NASDAQ:TLRY) vs. Pfizer (NYSE:PFE)
Tilray Brands, Inc. (NASDAQ:TLRY) Stock Rated "Hold" by Wall Street Brokerages
Tilray Brands (NASDAQ:TLRY) Stock Falls 4.6% - Here's Why
Top Cannabis Stocks To Watch Today - November 10th

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cumberland Pharmaceuticals stock logo

Cumberland Pharmaceuticals NASDAQ:CPIX

$6.57 +0.77 (+13.28%)
Closing price 04:00 PM Eastern
Extended Trading
$6.59 +0.02 (+0.30%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.

CorMedix stock logo

CorMedix NASDAQ:CRMD

$4.50 -0.17 (-3.64%)
Closing price 04:00 PM Eastern
Extended Trading
$4.58 +0.08 (+1.78%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

ARS Pharmaceuticals stock logo

ARS Pharmaceuticals NASDAQ:SPRY

$3.69 +0.04 (+1.10%)
Closing price 04:00 PM Eastern
Extended Trading
$3.69 +0.00 (+0.08%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Tilray Brands stock logo

Tilray Brands NASDAQ:TLRY

$2.25 -0.10 (-4.26%)
Closing price 04:00 PM Eastern
Extended Trading
$2.27 +0.02 (+1.07%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.